This Startup Just Raised $1.8M to Fix Psychiatry's Biggest Hidden Problem

ยท
Listen to this article~5 min

Copenhagen's Aisel Health raises $1.8M to build an AI operating system for psychiatry. Here's why AI scribes aren't enough and what this startup does differently.

Aisel Health, a Copenhagen-based HealthTech company, just closed a $1.8 million pre-Seed round. The news broke today, and it's turning heads in the mental health tech space. But here's the thing: this isn't another AI scribe startup. It's something far more interesting. The round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, and Angel Invest. Existing investors Rockstart and EIFO also joined in. That's a solid group of backers who clearly see something special here. ### The Real Problem in Psychiatry Here's what most people miss about mental health care: the notes are killing the doctors. Not the patients, not the paperwork itself, but the sheer chaos of finding information when it matters. Augusta Klingsten Peytz, co-founder and CEO of Aisel Health, puts it bluntly: "Psychiatry doesn't need more generic technology bolted onto an already overburdened workflow. It needs a product built around the realities of psychiatric care โ€“ where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can." She's not wrong. And that's the core insight driving this whole company. ### Why AI Scribes Aren't Enough Founded in 2024 by Peytz and Christian Houen, Aisel Health builds software that helps psychiatric clinics scale their operations. The goal? Surface the right information for clinicians at exactly the right moment. That means better patient experiences, less strain on staff, and healthier clinic profit margins. Now, you might be thinking: "Haven't we already got AI note-taking tools?" Yes, we do. But that's kind of the problem. According to Aisel Health, faster notes create a different headache. When documentation becomes cheap and quick to produce, the information inside it becomes harder to find. Patient records pile up across different systems, and suddenly the challenge shifts from writing notes to actually finding what matters. Their research, called "The Documentation Minute," found something striking. Psychiatrists spend far more time pulling together a patient's history from referrals, prior notes, and multiple systems than they do actually writing the note. It's a mess of fragmented information before they can even start assessing and treating. ### A Different Approach Christian Houen, co-founder and CPO, explains it this way: "AI scribes work โ€“ they write notes faster, and that's great for immediate burnout. But that's not what's keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it." So what does Aisel actually do differently? It turns interview recordings, existing documents, and the patient's own accounts into structured, contextual insights. Before, during, and after the consultation, the platform gives clinicians direct access to all documentation about the patient. No more digging through five different systems. ### Security and Compliance Built In Here's something that should matter to anyone in healthcare tech: Aisel Health doesn't have access to patients' medical records. Patient data is never used to train their AI models. And all data stays on secure servers within Europe, fully compliant with GDPR and local data protection regulations. That's a big deal in this industry. Carolin Gabor, Managing Partner and GP at Caesar Ventures, sums up the excitement: "Few problems in healthcare are as large or as overlooked as psychiatry's, and few founders are as passionate about solving it the way Augusta and Christian are. We're proud to lead this round." ### What's Next The funding will go toward growing their clinical and engineering teams, plus funding their UK market entry. They've got an active commercial pipeline in private psychiatry, and they're eyeing a Seed round down the road. It's early days, but this feels like one of those quiet moves that could actually reshape how psychiatric care operates. Worth keeping an eye on.